Table 3.
Dysport (n = 94) | Botox (n = 94) | P value | |
---|---|---|---|
Subjects with at least one AE, n (%) | 14 (14.9) | 19 (20.2) | 0.332 |
AEs by category, n (%) | |||
Severe | 0 (0.0) | 0 (0.0) | 1.000 |
Moderate | 0 (0.0) | 1 (1.1) | 1.000 |
Treatment-related | 14 (14.9) | 19 (20.2) | 0.332 |
Leading to discontinuation | 0 (0.0) | 0 (0.0) | 1.000 |
AEs by type, n (%) | |||
Neck muscle weakness | 9 (9.6) | 13 (13.8) | 0.388 |
Dysphagia | 6 (6.4) | 12 (12.8) | 0.070 |
Pain on neck and shoulder | 2 (2.1) | 7 (7.4) | 0.180 |
Local pain | 2 (2.1) | 1 (1.1) | 1.000 |
Neck rigidity | 1 (1.1) | 1 (1.1) | 1.000 |
Hoarseness | 1 (1.1) | 1 (1.1) | 1.000 |
Headache | 1 (1.1) | 0 (0.0) | 1.000 |
Dyspnea | 0 (0.0) | 1 (1.1) | 1.000 |
Paresthesia | 0 (0.0) | 1 (1.1) | 1.000 |
Dysarthria | 0 (0.0) | 1 (1.1) | 1.000 |
Fatigue | 0 (0.0) | 1 (1.1) | 1.000 |